APVO - Aptevo Therapeutics Stock Trading

Aptevo Therapeutics Inc.(NASDAQ: APVO) stock trading, description, contact, officers and directors.

About Aptevo Therapeutics Inc.

Not available

Stock Information

Aptevo Therapeutics Inc. Company Name:

APVO Stock Symbol:

NASDAQ Market:

Aptevo Therapeutics Inc. Website:

APVO - Aptevo Therapeutics Stock Trading

Get APVO Alerts

News, Short Squeeze, Breakout and More Instantly...

APVO - Aptevo Therapeutics Provides Update on Ongoing APVO436 Phase 1 Clinical Trial

Trial Advancing on Schedule and Second Patient Dosed in Cohort 7 No Evidence of Drug-Induced Anti-Drug Antibodies Observed to Date SEATTLE, WA / ACCESSWIRE / September 1, 2020 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a biotechnology company focused on developing novel immuno-onc...
APVO - Aptevo Therapeutics Reports Second Quarter 2020 Financial Results

Advances Phase 1/1b Clinical Trial of APVO436 for the Treatment of Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome; Cohort 6 Enrollment Complete Presents New Preclinical Data Showing That ALG.APV-527 has Potential for a Favorable Safety Profile Extends Cash ...
APVO - Aptevo Therapeutics Secures $25 Million Non-Dilutive Financing from Midcap Financial Trust

Extends Cash Runway into Q3 2021 The Current Cash Balance is Anticipated to Create a Sufficient Timeline to Complete the APVO 436 Phase I(a) Dosing Cohorts Which Pre-Clinical Modelling Predicts May Deliver an Efficacious Dose SEATTLE, WA / ACCESSWIRE / August 6, 2020 / Aptevo Thera...